Survival analysis by pooling risk factors in AVAGAST: First-line capecitabine and cisplatin plus bevacizumab (bev) or placebo (pla) in patients (pts) with advanced gastric cancer (AGC) Meeting Abstract
| Authors: | Kang, Y.; Ohtsu, A.; Van Cutsem, E.; Roman, L.; Nunes, J.; Li, C.; Otero, D.; Rivera, F.; Aprile, G.; Alvarez, P. R. P.; Moehler, M. H.; Wu, J.; Langer, B.; Shah, M. A. |
| Abstract Title: | Survival analysis by pooling risk factors in AVAGAST: First-line capecitabine and cisplatin plus bevacizumab (bev) or placebo (pla) in patients (pts) with advanced gastric cancer (AGC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880300529 |
| DOI: | 10.1200/jco.2011.29.15_suppl.4119 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4119 -- Source: Wos |
